"With this continued progress, we believe we are well positioned to complete enrollment in the NEPHRO CRRT Study this year and file the PMA for a targeted potential approval of Niyad in 2027" (CEO & ...
Your browser's bookmark mess has a fix, and it's actually simple — build a searchable library instead.